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Review Article
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Birth asphyxia in term neonates affects 1–2/1000 live births and results in the develop-
ment of hypoxic–ischaemic encephalopathy with devastating life-long consequences.
The majority of neuronal cell death occurs with a delay, providing the potential of a treat-
ment window within which to act. Currently, treatment options are limited to therapeutic
hypothermia which is not universally successful. To identify new interventions, we need
to understand the molecular mechanisms underlying the injury. Here, we provide an over-
view of the contribution of both oxidative stress and endoplasmic reticulum stress in the
development of neonatal brain injury and identify current preclinical therapeutic
strategies.
Introduction
Term neonates (>37 weeks gestation) who develop hypoxic–ischaemic encephalopathy (HIE), neonatal
encephalopathy or perinatal arterial stroke have a greater incidence of cerebral palsy, cognitive impair-
ment, developmental delay and epilepsy [1–3]. Clinical MRI studies report that perinatal hypoxic–
ischaemic brain injury is characterised by lesions in grey matter structures such as the basal ganglia,
thalamus and cortex, and to a lesser extent infarctions in white matter, where increasing severity is
predictive of poorer neurodevelopmental and motor outcome [4–6]. Currently, the only available
treatment is therapeutic hypothermia, where if initiated within 6 h can improve neurological outcome
[4,7]. The underlying mechanisms contributing to the development of perinatal brain injury have not
been entirely elucidated.
Studies from small and large animal models have shown that with advancing gestation, the develop-
ing brain is increasingly vulnerable to hypoxia–ischaemia (HI), with term age-equivalent models
showing greater vulnerability to neuronal cell death [8,9] in part due to their high metabolic demand
[9–11]. Following HI, cells initially undergo impaired cerebral oxidative metabolism, swelling and
extracellular accumulation of excitatory amino acids (primary phase) and transiently recover (latent
phase) prior to a period of secondary energy failure (secondary phase). Over subsequent hours to
days, the injurious mechanisms of the secondary phase lead to neuronal cell death. These include exci-
totoxicity, deterioration of mitochondrial function, inﬂammation, increased reactive oxygen species
(ROS) production and activation of nitric oxide synthase (NOS) and accumulation of intracellular Ca2+
[12–15]. We and others have identiﬁed mitochondrial dysfunction as the intracellular hub of these
injury responses following HI in the immature brain [16].
Mitochondria are key determinants of cell fate having the ability to induce cell death. Delayed cell
death that follows neonatal HI is morphologically characterised by either apoptotic (programmed),
necrotic (uncontrolled) and more recently, necroptotic (programmed necrosis) phenotype [11,16–21].
In comparison with the adult, the immature brain has a high expression of many pro-apoptotic
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proteins (including Bax, caspase-2, -3, -8 and -9) [22,23], and apoptosis occurs following mitochondrial outer
membrane permeabilisation (MOMP). Brieﬂy, Bax translocates from the cytosol to form Bax–Bak pores at the
outer membrane which allows for the release of pro-apoptotic proteins. Cytochrome c, apoptosis-inducing
factor (AIF), smac/Diablo and endonuclease G translocate from the mitochondria to the cytosol, and while
each has a different downstream target, all ultimately lead to apoptotic cell death [20–22,24–26]. Necroptosis is
linked with apoptosis as ligands such as tumour necrosis factor-alpha, TNF-related apoptosis-inducing ligand
and Fas can activate death receptors in both instances. However, caspase-8 appears to be the checkpoint that
determines whether a cell undergoes necroptosis (caspase-8-independent) or apoptosis [20,27]. Cell death is
obviously the endpoint of the induction of these pathways, but in order to design intelligent intervention, a
clear understanding of the mechanisms leading to the triggering of such signalling is required. Oxidative stress
and endoplasmic reticulum (ER) stress responses are rapidly induced following HI and contribute to cellular
injury and death in the immature brain. Here, we will brieﬂy outline how these stresses are generated in the
developing brain after HI and the potential for therapeutic intervention.
Oxidative stress and HIE
Oxidative stress occurs when the generation of ROS and reactive nitrogen species (RNS) exceeds the capability
of endogenous antioxidant systems. Under normal physiological conditions, low concentrations of ROS and
RNS can act as signalling molecules [28]. However, during reperfusion following the primary phase of HI,
there is a rapid production of free radicals. Aberrant glutamate receptor activation results in calcium inﬂux acti-
vating neuronal nitric oxide synthase (nNOS) to generate nitric oxide (NO; Figure 1). Superoxide (O2),
formed from leakage of electrons from complexes I and III of the electron transport chain, interacts with NO
to form peroxynitrite (ONOO−), leading to generation of hydroxyl radicals (·OH−); subsequent ·OH−-mediated
cellular impairment occurs through lipid peroxidation, protein oxidation, DNA damage and inhibition of mito-
chondrial function (speciﬁcally complex IV). Complexes I and IV are also targets for direct damage by
ONOO− (Figure 1). Excitotoxicity-mediated calcium inﬂux also triggers the formation of O2 through the
action of NADPH oxidase (NOX, [29]). O2 can be neutralised by superoxide dismutase (SOD), which con-
verts O2 into hydrogen peroxide (H2O2), subsequently converted into H2O by catalase. However, excessive
build-up of H2O2 can lead to further generation of
·OH− through the iron-based Fenton reaction.
The immature brain has a high oxygen consumption and consists of a high concentration of free iron, water
content and easily oxidised unsaturated fatty acids. In addition, low myelination and a low expression of anti-
oxidant enzymes [SOD and glutathione peroxidase (GPx)] consequently lead to an underdeveloped antioxidant
system, rendering it particularly vulnerable to oxidative damage, with both ROS and RNS strongly inﬂuencing
excitotoxicity, cell death and mitochondrial impairment [30–34].
Studies of neonates with HIE identiﬁed evidence of oxidative stress [35,36] as well as evidence suggesting
that therapeutic hypothermia reduced lipid peroxidation among its many beneﬁts [36]. It is therefore critical
that mechanisms speciﬁc to immature brain are identiﬁed in order to develop interventions. NOS and mito-
chondrial electron leakage are believed to be the major contributors of ROS/RNS in the immature brain [37,38]
Following HI in the neonatal rat, there is an increase in expression of hydroxyl radicals and free iron in ischae-
mic regions, and it was recently established that this was mediated in part by nitric oxide [39,40]. Both endo-
thelial nitric oxide synthase and nNOS are signiﬁcantly increased in the hours following HI [41,42].
Interestingly, the developmental expression pattern of nNOS is comparable to regions vulnerable to injury, and
nNOS knockout mice show less injury in response to HI [43–46]. Modulating expression of H2O2 has further
implicated ROS as detrimental following neonatal HI. Detoxifying enzyme GPx1, which decreases H2O2 levels,
has been shown to be protective to neonatal brain after HI [47], whereas overexpression of H2O2 which occurs
in mice that overexpress Cu/Zn SOD1, required to produce H2O2, is associated with exacerbation of the injury
after HI [48]. This could be due to the accumulation of H2O2 being exposed to high levels of free iron in the
immature brain moving the Fenton reaction towards generation of hydroxyl radicals (Figure 1). The role of
NOX is less clear in the immature brain. Superoxide production is rapidly increased in the immature mouse
brain after HI, coinciding with an increase in the expression of NOX subunits. This increase is functionally
coupled to phosphorylation of the NMDA receptor 2B (NR2B) subunit as mutation of this NR2B phosphoryl-
ation site reduces HI-induced up-regulation of expression of NOX2, suppresses superoxide formation and
reduces cell death [29]. However, genetic ablation of NOX subunits directly has no effect on infarct size and
may exacerbate brain damage in excitotoxicity models of immature injury [49]. Clearly, the complexity of these
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signalling pathways coupled with contributions from different neural cell types makes it difﬁcult to determine
the extent on NOX involvement.
Mitochondria are a major contributor to the generation of ROS but also sensitive to oxidative stress, which
can culminate in cell death (Figure 1) [38,50]. The release of cytochrome c from the mitochondria is a crucial
step in induction of the apoptotic pathway. For this to occur, it must be dissociated from the inner mitochon-
drial membrane where it is bound to cardiolipin (rich in polyunsaturated fatty acids). Numerous studies
suggest that increased ROS generation promotes cytochrome c release from the inner mitochondrial membrane
by acting as a catalyst in the oxidation of cardiolipin [51–53]. Independent of this, NO, peroxynitrite and
4-hydroxynononeal, a product of lipid peroxidation, have been shown to enhance mitochondrial permeabilisation
[54]. Downstream, once initiated, both caspase activation and necroptosis have been suggested to exacerbate
production of ROS [55,56].
Given that induction of ROS and RNS is an early event in the development of injury, it is unsurprising that
antioxidant therapies are being explored to combat neonatal HI-mediated brain injury. Among its many effects,
melatonin acts to scavenge free radicals and to induce expression of antioxidants. Its neuroprotective action was
promising in both small and large animal models of neonatal HI [57,58], and this has led to the initiation of
clinical trials. However, translation from immature preclinical models to clinical trials is not always straightfor-
ward as a mixed cell population such as the brain can lead to differential responses. This was highlighted
recently in trials of erythropoietin (EPO), where previous studies showed a high degree of neuroprotection in
neonatal models of HI hypothesised to be due to suppression of oxidative stress [59,60]. Very recent studies
identiﬁed that excessively high H2O2 expression resulted in EPO treatment worsening injury [61], and that
Figure 1. Schematic diagram of the production of ROS and nitrogen species following HI.
Increased intracellular calcium active NOS to generate NO. Superoxide (O2 ) interacts with NO to form ONOO− and
subsequently leads to generation of ·OH−. ONOO− itself can target the mitochondrial respiratory complexes directly. SOD also
converts O2  into H2O2, where excessive build-up of H2O2 leads to an exacerbated generation of
·OH− via the Fenton reaction.
All of these reactive oxygen and nitrogen species contribute to lipid peroxidation, DNA damage and harmful protein oxidation
in addition to inﬂuencing the release of pro-apoptotic proteins from the mitochondria to initiate cell death.
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differential effects were observed in astrocytes compared with microglia [62]. In a similar manner, allopurinol,
a free radical scavenger, provided beneﬁcial effects in animal models [63], which were difﬁcult to reproduce
consistently in clinical trials (reviewed in ref. [64]). Other antioxidants under consideration as neuroprotectants
in immature brain after HI include the plant polyphenol resveratrol [65] and n-acetylcysteine [66–69].
ER stress and HIE
The ER functions to synthesise and regulate protein folding of transmembrane and secreted proteins as well as
synthesising phospholipids and cholesterol, but, in addition, it is the site of the highest intracellular calcium
concentrations [70]. Therefore, it is unsurprising that pathological alterations in a wide range of intracellular
mechanisms culminate in ER stress, manifested as disturbed protein folding and accumulation of unfolded pro-
teins in the ER lumen. To maintain cellular homeostasis, the ER triggers the unfolded protein response (UPR)
[71,72] mediated by the chaperone protein glucose-regulated protein (GRP)78 also known as binding immuno-
globulin protein. GRP78 is localised in the lumen of the ER and is required for numerous ER functions [73].
Normally, GRP78 binds to and inhibits the activation of the UPR sensors inositol-requiring enzyme (IRE)1,
protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating transcription factor (ATF)6,
transmembrane proteins, which possess GFP78-binding sites in their ER lumen portions (Figure 2A). However,
accumulation of unfolded proteins results in the sequestering of GRP78 away from these UPR sensors leading
to regulation of protein synthesis and increased degradation of unfolded proteins, either through autophagy or
ER-activated degradation (ERAD).
Figure 2. The response of the ER during homeostasis and under mild and chronic stress.
(A) During homeostasis when normal protein folding occurs, chaperone protein glucose-related protein (GRP)78 binds
transmembrane proteins IRE1, ATF6 and PERK in the ER. (B) Following mild stress leading to misfolding of proteins, the ER
initiates the UPR cascade, releasing GRP78 to chaperone proper protein folding. Activated transmembrane proteins damp
down protein synthesis except for proteins required for the UPR to restore equilibrium. (C) Severe, prolonged stress to the ER
can induce cell death that overwhelms the UPR and culminates in cell death through many mechanisms.
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Once released from GRP78, IRE1 oligomerises, becomes phosphorylated and utilises its endoribonuclease
domain to degrade RNA, reducing the burden on the ER. In addition, IRE1 splices and activates XBP1, which
translocates to the nucleus, up-regulating expression of key proteins required to manage both the stress
response (e.g. chaperones GRP78 and GRP94) and improved clearing of unfolded proteins (ERAD) [74]. In
addition to degradation by ERAD, both PERK and IRE1 can trigger autophagy in response to ER stress.
Oligomerised, phosphorylated PERK down-regulates general protein synthesis through phosphorylating and
inactivating elongation initiation factor (eIF)2α. However, translation of selective mRNAs is up-regulated after
eIF2α inhibition, e.g. ATF4, which can induce the expression of C/EBP-homologous protein (CHOP). PERK
also phosphorylates NRF2 resulting in its activation and increased antioxidant response [75]. Finally, ATF6
translocates to the Golgi where it is cleaved, becoming an active transcription factor capable of up-regulating
expression of chaperones, as well as CHOP and XBP1 (Figure 2B) [76].
Pathological signalling events triggered by birth asphyxia disrupt cellular homeostasis and as such lead to the
induction of ER stress and the UPR [77]. Using a well-characterised rat model of neonatal HI, Puka-Sundvall
et al. [19] demonstrated that there is a signiﬁcant accumulation of calcium in the ER with clear increases from
30 min to 3 h following HI injury. In cortical neurones subjected to oxygen-glucose deprivation (an in vitro
mimic of HI), phosphorylation of PERK, IRE1 and cleavage of ATF6 is observed to occur rapidly after injury
[78]. Phosphorylation of PERK and eIF2α also occurs rapidly and transiently in vivo after neonatal HI in
term-equivalent mice as well as an up-regulation of GRP78 and CHOP [78–81].
Although the aim of the UPR is to restore proteostasis and cellular homeostasis, severe ER stress and pro-
longed activation of the above pathways can induce cell death (Figure 2C) [76]. Prolonged activation of PERK
can result in expression of Noxa which induces Bax localisation to the mitochondrial outer membrane resulting
in its permeabilisation and induction of apoptosis [82]. Bax-mediated mitochondrial outer membrane perme-
abilisation is a hallmark of secondary brain injury in neonatal HI [23,83]. Similarly, ATF6 will induce
pro-apoptotic Bim expression [84], while IRE1 recruits TRAF2 and downstream JNK signalling to inhibit anti-
apoptotic Bcl-2 protein expression [85]. Induction of death receptor expression is also a consequence of pro-
longed ER stress (Figure 2C) [86]. As all these pro- and anti-apoptotic effects are observed in the development
of injury in neonatal HI [87–90], it is tempting to speculate that targeting prolonged ER stress may represent
an intervention point for the early inhibition of cell death mechanisms triggered after neonatal HI.
Although the mechanisms are not as clearly deﬁned, prolonged ER stress can also induce the up-regulation
of autophagy and phosphorylation of key signalling molecules in the necroptotic (regulated necrosis) cell death
pathway. Inhibition of necroptosis is neuroprotective after HI in vivo [91], and ER stress is reported to function
upstream of necroptosis in this model [92]. Prolonged ER stress can also result in cross-talk with autophagy
Table 1 Reducing ER stress is neuroprotective in rodent models of neonatal HI
Treatment Species/delivery Outcome Ref.
Basic fibroblast growth
factor (bFGF)
Rat (P7)/intranasal Reduced ER stress (ATF6, GRP78, XBP-1,
ATF4 and CHOP)
Reduced infarct volume
[80]
Acidic fibroblast growth
factor (aFGF)
Rat (P7)/intranasal Reduced ER stress (ATF6, GRP78, XBP-1,
ATF4 and CHOP)
Reduced infarct volume
[100]
Necrostatin-1 (Nec-1) Mice (P7)/
intracerebroventricular
Reduced ER stress (GRP78, PERK, peIF1a,
XBP1, GADD34 and CHOP)
EM (organelle pathology)
[92]
Hydrogen-rich saline Mice (P7)/intraperitoneal Reduced ER stress (GRP78 and CHOP)
Reduced infarct volume
[101]
Notoginsenoside R1 (NGR1) Rats (P7)/intraperitoneal Reduced ER stress (GRP78, PERK, IRE1α,
CHOP and BCL-2)
Reduced infarct volume
[79]
Melatonin Rats (P7)/intraperitoneal Reduced ER stress (GRP78, PERK, IRE1α,
CHOP and XBP-1)
Reduced infarct volume
[102]
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when the ERAD degradation of proteins becomes overwhelmed [93]. In animal and cellular models of mito-
chondrial respiratory complex diseases, both ER stress and autophagy were recently found to be up-regulated
as a consequence of disease-induced translation dysfunction and proteotoxic stress [94]. This elegant study by
Peng et al. found that rather than targeting the complexes themselves, signiﬁcant mitochondrial functional ben-
eﬁts were instead conferred by inhibiting the downstream consequences. In particular, low-dose cycloheximide
and probucol (an anti-hyperlipidemic drug in clinical use) were very effective in preventing the induction of
ER stress and the up-regulation of autophagy, promoting oxidative phosphorylation, cell survival in vitro and
reduced disease severity in vivo [94]. Aberrant autophagy is also reported in the in vivo model of HI, although
whether the pathway acts in a beneﬁcial or deleterious manner is currently unclear [81,95,96].
Compared with the ﬁeld of oxidative stress in neonatal HI (see above), there are signiﬁcantly fewer neuropro-
tective interventions targeting ER stress. However, many recent studies have identiﬁed neuroprotective para-
digms in in vivo rodent models of neonatal HI, which act through the prevention of prolonged ER stress
(Table 1). None of these neuroprotectants targets ER stress uniquely (e.g. melatonin also act as a free radical
scavenger), and it remains to be seen whether these potential therapies will offer synergistic efﬁcacy with hypo-
thermia, the current standard of care, or whether they represent ‘stand-alone’ treatments.
Conclusion
The molecular mechanisms underlying the development of brain injury in neonates who have suffered birth
asphyxia remain unclear and providing treatment options is a critical, unmet clinical need. The recent ava-
lanche of preclinical data has identiﬁed many key pathways activated early in the development of the pathology
and which may be amenable to therapeutic intervention. Here, we have distilled the recent evidence regarding
induction of oxidative stress and ER stress signalling after HI injury in the immature brain. More is currently
understood about oxidative stress than ER stress in the immature brain. Mice genetically modiﬁed to alter the
expression of the ER transmembrane receptors may provide more speciﬁc clues as to the contribution of ER
stress in the development of neonatal brain injury. However, it is impossible to consider these areas in isolation.
Although due to their complexity it is hard to evaluate this cross-talk experimentally, there are a few examples
emerging. For example, induction of ER stress in macrophages is reported to result in increased NOX expres-
sion and subsequent apoptosis is mediated by CHOP [97], and a member of the GPx family promotes the
function of GRP78 [98]. More generally, ROS can also be produced in the ER as a by-product of protein
folding, upsetting the critical redox balance within the ER lumen, inducing downstream oxidative stress
responses and disrupting cellular homeostasis which feeds back to exacerbate ER stress further [99]. Identifying
drugs which can tackle multiple targets within these pathways, e.g. melatonin, may prove to be the key in the
development of potential interventions to ameliorate brain injury in these vulnerable neonates.
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35 Mutlu, M., Sariaydin, M., Aslan, Y., Kader, Ş., Dereci, S., Kart, C. et al. (2016) Status of vitamin D, antioxidant enzymes, and antioxidant substances in
neonates with neonatal hypoxic-ischemic encephalopathy. J. Matern. Fetal Neonatal Med. 29, 2259–2263 doi:10.3109/14767058.2015.1081889
36 Perrone, S., Szabó, M., Bellieni, C.V., Longini, M., Bangó, M., Kelen, D. et al. (2010) Whole body hypothermia and oxidative stress in babies with
hypoxic-ischemic brain injury. Pediatr. Neurol. 43, 236–240 doi:10.1016/j.pediatrneurol.2010.05.009
37 Zhao, M., Zhu, P., Fujino, M., Zhuang, J., Guo, H., Sheikh, I.A. et al. (2016) Oxidative stress in hypoxic-ischemic encephalopathy: molecular
mechanisms and therapeutic strategies. Int. J. Mol. Sci. 17, 2078 doi:10.3390/ijms17122078
38 Blomgren, K. and Hagberg, H. (2006) Free radicals, mitochondria, and hypoxia–ischemia in the developing brain. Free Radic. Biol. Med. 40, 388–397
doi:10.1016/j.freeradbiomed.2005.08.040
39 Palmer, C., Menzies, S.L., Roberts, R.L., Pavlick, G. and Connor, J.R. (1999) Changes in iron histochemistry after hypoxic-ischemic brain injury in the
neonatal rat. J. Neurosci. Res. 56, 60–71 doi:10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A
40 Lu, Q., Harris, V.A., Raﬁkov, R., Sun, X., Kumar, S. and Black, S.M. (2015) Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the
disruption of neuronal iron metabolism. Redox Biol. 6, 112–121 doi:10.1016/j.redox.2015.06.007
41 van den Tweel, E.R.W., Nijboer, C., Kavelaars, A., Heijnen, C.J., Groenendaal, F. and van Bel, F. (2005) Expression of nitric oxide synthase isoforms and
nitrotyrosine formation after hypoxia–ischemia in the neonatal rat brain. J. Neuroimmunol. 167, 64–71 doi:10.1016/j.jneuroim.2005.06.031
42 Ergenekon, E. and Gücüyener, K. (1998) Nitric oxide in developing brain. Eur. J. Paediatr. Neurol. 2, 297–301 doi:10.1016/S1090-3798(98)80004-4
43 Black, S.M., Bedolli, M.A., Martinez, S., Bristow, J.D., Ferriero, D.M. and Soifer, S.J. (1995) Expression of neuronal nitric oxide synthase corresponds to
regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol. Dis. 2, 145–155 doi:10.1006/nbdi.1995.0016
44 Ferriero, D.M., Holtzman, D.M., Black, S.M. and Sheldon, R.A. (1996) Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to
hypoxic–ischemic injury. Neurobiol. Dis. 3, 64–71 doi:10.1006/nbdi.1996.0006
45 Muramatsu, K., Sheldon, R.A., Black, S.M., Täuber, M. and Ferriero, D.M. (2000) Nitric oxide synthase activity and inhibition after neonatal hypoxia
ischemia in the mouse brain. Dev. Brain Res. 123, 119–127 doi:10.1016/S0165-3806(00)00088-2
46 Ferriero, D.M., Sheldon, R.A., Black, S.M. and Chuai, J. (1995) Selective destruction of nitric oxide synthase neurons with quisqualate reduces damage
after hypoxia-ischemia in the neonatal rat. Pediatr. Res. 38, 912–918 doi:10.1203/00006450-199512000-00014
47 Sheldon, R.A., Christen, S. and Ferriero, D.M. (2008) Genetic and pharmacologic manipulation of oxidative stress after neonatal hypoxia-ischemia.
Int. J. Dev. Neurosci. 26, 87–92 doi:10.1016/j.ijdevneu.2007.08.010
48 Ditelberg, J.S., Sheldon, R.A., Epstein, C.J. and Ferriero, D.M. (1996) Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc
superoxide dismutase transgenic mice. Pediatr. Res. 39, 204–208 doi:10.1203/00006450-199602000-00003
49 Doverhag, C., Keller, M., Karlsson, A., Hedtjarn, M., Nilsson, U., Kapeller, E. et al. (2008) Pharmacological and genetic inhibition of NADPH oxidase
does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol. Dis. 31, 133–144 doi:10.1016/j.nbd.2008.04.
003
50 Turrens, J.F. (2003) Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335–344 doi:10.1113/jphysiol.2003.049478
51 Petrosillo, G., Ruggiero, F.M. and Paradies, G. (2003) Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria.
FASEB J. 17, 2202–2208 doi:10.1096/fj.03-0012com
52 Petrosillo, G., Ruggiero, F.M., Pistolese, M. and Paradies, G. (2001) Reactive oxygen species generated from the mitochondrial electron transport chain
induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett. 509,
435–438 doi:10.1016/S0014-5793(01)03206-9
53 Kagan, V.E., Tyurin, V.A., Jiang, J., Tyurina, Y.Y., Ritov, V.B., Amoscato, A.A. et al. (2005) Cytochrome c acts as a cardiolipin oxygenase required for
release of proapoptotic factors. Nat. Chem. Biol. 1, 223–232 doi:10.1038/nchembio727
54 Vieira, H.L.A., Belzacq, A.-S., Haouzi, D., Bernassola, F., Cohen, I., Jacotot, E. et al. (2001) The adenine nucleotide translocator: a target of nitric oxide,
peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305–4316 doi:10.1038/sj.onc.1204575
55 Dixon, S.J. and Stockwell, B.R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17 doi:10.1038/nchembio.
1416
56 Ricci, J.-E., Muñoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G.A., Yadava, N. et al. (2004) Disruption of mitochondrial function during
apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773–786 doi:10.1016/j.cell.2004.
05.008
57 Husson, I., Mesplès, B., Bac, P., Vamecq, J., Evrard, P. and Gressens, P. (2002) Melatoninergic neuroprotection of the murine periventricular white
matter against neonatal excitotoxic challenge. Ann. Neurol. 51, 82–92 doi:10.1002/ana.10072
58 Welin, A.-K., Svedin, P., Lapatto, R., Sultan, B., Hagberg, H., Gressens, P. et al. (2007) Melatonin reduces inﬂammation and cell death in white matter
in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 61, 153–158 doi:10.1203/01.pdr.0000252546.20451.1a
59 Kellert, B.A., McPherson, R.J. and Juul, S.E. (2007) A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal
rats. Pediatr. Res. 61, 451–455 doi:10.1203/pdr.0b013e3180332cec
60 Gonzalez, F.F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z. et al. (2007) Erythropoietin enhances long-term neuroprotection and
neurogenesis in neonatal stroke. Dev. Neurosci. 29, 321–330 doi:10.1159/000105473
61 Sheldon, R.A., Windsor, C., Lee, B.S., Arteaga Cabeza, O. and Ferriero, D.M. (2017) Erythropoietin treatment exacerbates moderate injury after
hypoxia-ischemia in neonatal superoxide dismutase transgenic mice. Dev. Neurosci. 39, 228–237 doi:10.1159/000472710
62 Pathipati, P. and Ferriero, D.M. (2017) The differential effects of erythropoietin exposure to oxidative stress on microglia and astrocytes in vitro. Dev.
Neurosci. 39, 310–322 doi:10.1159/000467391
© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).1074
Biochemical Society Transactions (2017) 45 1067–1076
DOI: 10.1042/BST20170017
63 Palmer, C., Towﬁghi, J., Roberts, R.L. and Heitjan, D.F. (1993) Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old
rats. Pediatr. Res. 33, 405–411 doi:10.1203/00006450-199304000-00018
64 Arteaga, O., Álvarez, A., Revuelta, M., Santaolalla, F., Urtasun, A. and Hilario, E. (2017) Role of antioxidants in neonatal hypoxic–ischemic brain injury:
new therapeutic approaches. Int. J. Mol. Sci. 18, 265 doi:10.3390/ijms18020265
65 Pan, S., Li, S., Hu, Y., Zhang, H., Liu, Y., Jiang, H. et al. (2016) Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia.
Oncotarget 7, 79247–79261 doi:10.18632/oncotarget.13018
66 Nie, X., Lowe, D.W., Rollins, L.G., Bentzley, J., Fraser, J.L., Martin, R. et al. (2016) Sex-speciﬁc effects of N-acetylcysteine in neonatal rats treated with
hypothermia after severe hypoxia-ischemia. Neurosci. Res. 108, 24–33 doi:10.1016/j.neures.2016.01.008
67 Lee, T.-F., Tymaﬁchuk, C.N., Bigam, D.L. and Cheung, P.-Y. (2008) Effects of postresuscitation N-acetylcysteine on cerebral free radical production and
perfusion during reoxygenation of hypoxic newborn piglets. Pediatr. Res. 64, 256–261 doi:10.1203/PDR.0b013e31817cfcc0
68 Lee, T.-F., Jantzie, L.L., Todd, K.G. and Cheung, P.-Y. (2008) Postresuscitation N-acetylcysteine treatment reduces cerebral hydrogen peroxide in the
hypoxic piglet brain. Intensive Care Med. 34, 190–197 doi:10.1007/s00134-007-0880-z
69 Kannan, S., Dai, H., Navath, R.S., Balakrishnan, B., Jyoti, A., Janisse, J. et al. (2012) Dendrimer-based postnatal therapy for neuroinﬂammation and
cerebral palsy in a rabbit model. Sci. Transl. Med. 4, 130–146 doi:10.1126/scitranslmed.3003162
70 Xu, C., Bailly-Maitre, B. and Reed, J.C. (2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656–2664
doi:10.1172/JCI26373
71 Wang, M. and Kaufman, R.J. (2016) Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature 529, 326–335
doi:10.1038/nature17041
72 Hetz, C., Chevet, E. and Oakes, S.A. (2015) Proteostasis control by the unfolded protein response. Nat. Cell Biol. 17, 829–838 doi:10.1038/ncb3184
73 Wang, M., Wey, S., Zhang, Y., Ye, R. and Lee, A.S. (2009) Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and
neurological disorders. Antioxid. Redox Signal. 11, 2307–2316 doi:10.1089/ars.2009.2485
74 Chen, Y. and Brandizzi, F. (2013) IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 23, 547–555 doi:10.1016/j.tcb.2013.06.005
75 Liu, Z., Lv, Y., Zhao, N., Guan, G. and Wang, J. (2015) Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate.
Cell Death Dis. 6, e1822 doi:10.1038/cddis.2015.183
76 Iurlaro, R. and Muñoz-Pinedo, C. (2016) Cell death induced by endoplasmic reticulum stress. FEBS J. 283, 2640–2652 doi:10.1111/febs.13598
77 Bueter, W., Dammann, O. and Leviton, A. (2009) Endoplasmic reticulum stress, inﬂammation, and perinatal brain damage. Pediatr. Res. 66, 487–494
doi:10.1203/PDR.0b013e3181baa083
78 Badiola, N., Penas, C., Miñano-Molina, A., Barneda-Zahonero, B., Fado, R., Sánchez-Opazo, G. et al. (2011) Induction of ER stress in response to
oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12. Cell Death Dis. 2, e149
doi:10.1038/cddis.2011.31
79 Wang, Y., Tu, L., Li, Y., Chen, D. and Wang, S. (2016) Notoginsenoside R1 protects against neonatal cerebral hypoxic-ischemic injury through estrogen
receptor-dependent activation of endoplasmic reticulum stress pathways. J. Pharmacol. Exp. Ther. 357, 591–605 doi:10.1124/jpet.115.230359
80 Lin, Z., Hu, Y., Wang, Z., Pan, S., Zhang, H., Ye, L. et al. (2017) Intranasal basic ﬁbroblast growth factor attenuates endoplasmic reticulum stress and
brain injury in neonatal hypoxic-ischaemic injury. Am. J. Transl. Res. 9, 275–288 PMID:28337259
81 Carloni, S., Albertini, M.C., Galluzzi, L., Buonocore, G., Proietti, F. and Balduini, W. (2014) Increased autophagy reduces endoplasmic reticulum stress
after neonatal hypoxia–ischemia: role of protein synthesis and autophagic pathways. Exp. Neurol. 255, 103–112 doi:10.1016/j.expneurol.2014.03.002
82 Zhang, L., Lopez, H., George, N.M., Liu, X., Pang, X. and Luo, X. (2011) Selective involvement of BH3-only proteins and differential targets of Noxa in
diverse apoptotic pathways. Cell Death Differ. 18, 864–873 doi:10.1038/cdd.2010.152
83 Wang, X., Han, W., Du, X., Zhu, C., Carlsson, Y., Mallard, C. et al. (2010) Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury.
Stroke 41, 2050–2055 doi:10.1161/STROKEAHA.110.589051
84 Puthalakath, H., O’Reilly, L.A., Gunn, P., Lee, L., Kelly, P.N., Huntington, N.D. et al. (2007) ER stress triggers apoptosis by activating BH3-only protein
Bim. Cell 129, 1337–1349 doi:10.1016/j.cell.2007.04.027
85 Urano, F., Wang, X.Z., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P. et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases
by transmembrane protein kinase IRE1. Science 287, 664–666 doi:10.1126/science.287.5453.664
86 Martín-Pérez, R., Niwa, M. and López-Rivas, A. (2012) ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and
PERK-dependent up-regulation of TRAIL-R2. Apoptosis 17, 349–363 doi:10.1007/s10495-011-0673-2
87 Kichev, A., Rousset, C.I., Baburamani, A.A., Levison, S.W., Wood, T.L., Gressens, P. et al. (2014) Tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inﬂammation. J. Biol. Chem. 289,
9430–9439 doi:10.1074/jbc.M113.512350
88 Nijboer, C.H., van der Kooij, M.A., van Bel, F., Ohl, F., Heijnen, C.J. and Kavelaars, A. (2010) Inhibition of the JNK/AP-1 pathway reduces neuronal
death and improves behavioral outcome after neonatal hypoxic–ischemic brain injury. Brain Behav. Immun. 24, 812–821 doi:10.1016/j.bbi.2009.09.
008
89 Nijboer, C.H., Heijnen, C.J., van der Kooij, M.A., Zijlstra, J., van Velthoven, C.T.J., Culmsee, C. et al. (2011) Targeting the p53 pathway to protect the
neonatal ischemic brain. Ann. Neurol. 70, 255–264 doi:10.1002/ana.22413
90 Pirianov, G., Brywe, K.G., Mallard, C., Edwards, A.D., Flavell, R.A., Hagberg, H. et al. (2007) Deletion of the c-Jun N-terminal kinase 3 gene protects
neonatal mice against cerebral hypoxic–ischaemic injury. J. Cereb. Blood Flow Metab. 27, 1022–1032 doi:10.1038/sj.jcbfm.9600413
91 Chavez-Valdez, R., Martin, L.J., Flock, D.L. and Northington, F.J. (2012) Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes
following neonatal hypoxia–ischemia. Neuroscience 219, 192–203 doi:10.1016/j.neuroscience.2012.05.002
92 Chavez-Valdez, R., Flock, D.L., Martin, L.J. and Northington, F.J. (2016) Endoplasmic reticulum pathology and stress response in neurons precede
programmed necrosis after neonatal hypoxia-ischemia. Int. J. Dev. Neurosci. 48, 58–70 doi:10.1016/j.ijdevneu.2015.11.007
93 Høyer-Hansen, M. and Jäättelä, M. (2007) Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death
Differ. 14, 1576–1582 doi:10.1038/sj.cdd.4402200
94 Peng, M., Ostrovsky, J., Kwon, Y.J., Polyak, E., Licata, J., Tsukikawa, M. et al. (2015) Inhibiting cytosolic translation and autophagy improves health in
mitochondrial disease. Hum. Mol. Genet. 24, 4829–4847 doi:10.1093/hmg/ddv207
© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 1075
Biochemical Society Transactions (2017) 45 1067–1076
DOI: 10.1042/BST20170017
95 Xie, C., Ginet, V., Sun, Y., Koike, M., Zhou, K., Li, T. et al. (2016) Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury.
Autophagy 12, 410–423 doi:10.1080/15548627.2015.1132134
96 Xu, Y., Tian, Y., Tian, Y., Li, X. and Zhao, P. (2016) Autophagy activation involved in hypoxic-ischemic brain injury induces cognitive and memory
impairment in neonatal rats. J. Neurochem. 139, 795–805 doi:10.1111/jnc.13851
97 Li, G., Scull, C., Ozcan, L. and Tabas, I. (2010) NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce
apoptosis. J. Cell Biol. 191, 1113–1125 doi:10.1083/jcb.201006121
98 Wei, P.-C., Hsieh, Y.-H., Su, M.-I., Jiang, X., Hsu, P.-H., Lo, W.-T. et al. (2012) Loss of the oxidative stress sensor NPGPx compromises GRP78
chaperone activity and induces systemic disease. Mol. Cell 48, 747–759 doi:10.1016/j.molcel.2012.10.007
99 Zeeshan, H.M., Lee, G.H., Kim, H.-R. and Chae, H.-J. (2016) Endoplasmic reticulum stress and associated ROS. Int. J. Mol. Sci. 17, 327 doi:10.3390/
ijms17030327
100 Hu, Y., Wang, Z., Pan, S., Fang, M., Jiang, H., Mao, Y. et al. (2017) Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effect
of aFGF in neonatal hypoxic-ischaemic brain injury. Oncotarget, in press doi:10.18632/oncotarget.17524
101 Bai, X., Liu, S., Yuan, L., Xie, Y., Li, T., Wang, L. et al. (2016) Hydrogen-rich saline mediates neuroprotection through the regulation of endoplasmic
reticulum stress and autophagy under hypoxia-ischemia neonatal brain injury in mice. Brain Res. 1646, 410–417 doi:10.1016/j.brainres.2016.06.020
102 Carloni, S., Albertini, M.C., Galluzzi, L., Buonocore, G., Proietti, F. and Balduini, W. (2014) Melatonin reduces endoplasmic reticulum stress and
preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia. J. Pineal Res. 57, 192–199 doi:10.1111/jpi.12156
© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).1076
Biochemical Society Transactions (2017) 45 1067–1076
DOI: 10.1042/BST20170017
